HAPLN3 acts as an oncogenic factor in cells, and a loss of HAPLN3 hinders the ability of clear cell renal cell carcinoma (ccRCC) cells to proliferate, migrate, and invade by suppressing activation of ERK1/2 [114]. This evidence concerns the gene MAPK3 and nonpapillary renal cell carcinoma.